(NASDAQ: KPRX) Kiora Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 114.47%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.4%.
Kiora Pharmaceuticals's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast KPRX's revenue for 2026 to be $5,627,241, with the lowest KPRX revenue forecast at $5,406,564, and the highest KPRX revenue forecast at $5,792,748. On average, 3 Wall Street analysts forecast KPRX's revenue for 2027 to be $0, with the lowest KPRX revenue forecast at $0, and the highest KPRX revenue forecast at $0.
In 2028, KPRX is forecast to generate $85,442,108 in revenue, with the lowest revenue forecast at $82,091,509 and the highest revenue forecast at $87,954,138.